Hot flash therapies in breast cancer survivors.
More than 86% of those diagnosed with invasive breast cancer are expected to survive for >/= 5 years after their diagnosis. Approximately 75% of postmenopausal women who had breast cancer report experiencing hot flashes. More than 90% of young survivors also experience hot flashes, which can be more severe and long lasting, with iatrogenic ovarian ablation or antiestrogen therapy. There are numerous options for the treatment of hot flashes. Not one treatment fits all. Some treatments are generally more effective than others, and each has different side effects. This review is meant to provide the basic information needed to make a decision about the best treatment for a breast survivor experiencing hot flashes.
Chang
Yuan-Ching
YC
Department of Surgery, Mackay Memorial Hospital, Taipei, Taiwan Mackay Medicine, Nursing and Management College, Taipei, Taiwan The University of Oklahoma Breast Institute, University of Oklahoma Health Sciences Center, Oklahoma City.
Parker
Jeanene
J
Dooley
William C
WC